Dr. David López Bravo

Dr. David López Bravo has a diverse work experience spanning various industries and roles. Dr. David is the Founder and CEO at Pannex Therapeutics since August 2020. In 2021, they also joined IndieBio as a Class 3 participant. Prior to these positions, they worked as a Generation 5 Alumni at GaneshaLab from September 2020 to January 2022. Dr. David also served as an International Business Development Consultant at Kiron Biotech from January 2020 to August 2020. With a strong background in research, Dr. Bravo was the Chief Research Officer at Kiron from June 2014 to August 2020. Dr. David pursued their PHD at Universidad de Santiago de Chile from August 2012 to December 2015. Dr. David also worked as a Docente Escuela de Kinesiología at Universidad Bernardo O´Higgins from August 2011 to December 2015 and as a Redactor de Proyectos - Venturelab at Universidad Adolfo Ibáñez from March 2012 to December 2012.

Dr. David López Bravo obtained their Licenciatura degree in Kinesiología from the Universidad Metropolitana de Ciencias de la Educación. Dr. David pursued further education and completed their Doctor of Philosophy (PhD) in Neuroscience at the Universidad de Santiago de Chile.